XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

75,411 resources

By Version

R2: 0
R2B: 0
R3: 3,448
R4: 55,341
R4B: 3,134
R5: 13,264
R6: 224

By Authority

none: 25,640
hl7: 42,405
ihe: 1,382
national: 3,470
who: 2,514

By Realm

none: 22,398
au: 648
be: 387
br: 299
ca: 764
ch: 1,527
cl: 469
cr: 45
cz: 384
de: 2,066
dk: 1,474
ee: 276
eu: 1,253
fi: 87
fr: 1,545
il: 308
in: 163
it: 181
jp: 293
kr: 5
nl: 2,153
no: 26
nz: 79
pl: 83
se: 29
sl: 2
stt: 116
tw: 901
uk: 97
us: 19,481
uv: 17,592
vn: 107
other: 7

Start Prev Rows 47600 - 47800 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1093	Strabismus SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1094	Strabismus I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1095	Strabismus	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1096	Overactive bladder SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1097	Overactive bladder I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1098	Overactive bladder	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1099	Movement disorders SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.110	CKD stage4above SCT	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1100	Movement disorders I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1101	Movement disorders	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1102	Lateral epicondylitis SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1103	Lateral epicondyltisis I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1104	Lateral epicondylitis	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1105	Plantar fasciitis SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1106	Plantar fasciitis I10	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1107	Plantar fasciitits	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1108	Cardiac CT SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1109	Cardiac CT CPT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.111	CKD stage4above	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1111	Cardiac CT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1112	Cardiac MRI SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1113	Cardiac MRI CPT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1114	Cardiac MRI	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1115	CT Angiography of Coronary Artery SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1116	CT Angiography of Coronary Artery CPT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1117	CT Angiography of Coronary Artery	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.120	Diabetic ketoacidosis SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.121	Diabetic ketoacidosis	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.146	Long Acting Muscarinic Antagonists (LAMA)	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.159	conditions_COPD I10	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.175	Asthma	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.184	DigTx Virtual Reality Contraindications Visual Impairment	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.186	Beta blockers GDMT for heart failure	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.188	medications_heart failure	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.197	Blood (Serum and Plasma) Potassium	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.214	Type 1 Diabetes Mellitus SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.238	MRA mineralocorticoid receptor antagonists	active	2024-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.244	MRA Mineralocorticoid Receptor Antagonist Allergy	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.260	UACR SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.263	Pregnancy I10	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.281	Statins Allergy SCT	active	2023-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.282	Statin Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.314	relatedconditions_hyperlipidemia I10	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.337	Migraine I10	active	2023-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.34	Blood pressure panel	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.35	Systolic Blood Pressure	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.367	Trandolapril	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.369	Candesartan	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.377	Valsartan	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.397	eGFR	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.412	Statin Moderate Intensity	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.415	LDL Cholesterol	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.43	Urinalysis	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.434	Insulin	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.437	TZD Thiazolidinediones	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.438	medications_T2DM	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.440	relatedconditions_T2DM SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.442	Blood Glucose	active	2024-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.459	Liver cancer	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.47	ACE inhibitor allergy SCT	active	2022-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.474	Allergy to Tdap Vaccine	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.475	Allergy to Td Vaccine	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.481	medications_hypertension	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.492	Inhaled Corticosteroids Allergy	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.498	Metformin AllergyIntolerance SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.508	Abdominal aortic imaging CPT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.517	Hemoglobin A1c	active	2024-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.518	Drug hypersensitivity I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.519	Drug hypersensitivity SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.520	Drug hypersensitivity	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.521	Diabetic Kidney Disease I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.523	Diabetic kidney disease	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.524	Chronic Hepatitis SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.525	Chronic Hepatitis	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.527	OCS_Prednisone	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.531	Anti IgE Medications	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.532	IL5 Antagonists	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.533	Mast cell stabilizers for asthma	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.534	Vasospastic disease I10	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.535	Vasospastic disease SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.536	Vasospastic disease	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.537	Hemiplegic and basilar migraine I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.538	Hemiplegic and basilar migraine SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.539	Hemiplegic and basilar migraine	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.540	Peptic ulcer disease I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.541	Peptic ulcer disease SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.542	Peptic ulcer disease	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.544	Bleeding disorder I10	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.545	Bleeding disorder SCT	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.548	Electronic cigarettes or Vaping	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.549	Bleeding disorder	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.552	Triptans	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.553	CGRP receptor antagonists	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.554	Ditans	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.555	Ergots	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.556	Migraine specific NSAIDs	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.557	OTC migraine analgesics	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.559	medications_migraine_acute	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.560	relatedconditions_migraine I10	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.561	conditions_migraine	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.562	relatedconditions_migraine SCT	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.563	relatedconditions_migraine	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.564	Triptan Allergy Intolerance SCT	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.565	Triptan Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.566	Ischemic bowel disease SCT	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.567	Ischemic bowel disease I10	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.568	Ischemic bowel disease	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.573	conditions_hyperlipidemia I10	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.574	conditions_hyperlipidemia SCT	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.575	conditions_hyperlipidemia	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.578	PIM_Schedule V	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.580	PIM_Acarbose	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.582	PIM_Dulaglutide	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.583	PIM_Glimepiride	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.585	PIM_Glucophage	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.587	PIM_Glucovance	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.588	Glyburide PIM	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.590	Alpha glucosidase inhibitors	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.592	Azotemia	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.594	Intolerance to ARB SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.595	ICS Low	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.596	ICS Medium	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.597	ICS High	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.598	Low Dose ICS Formoterol	active	2024-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.600	PIM_Vitamin B12 Level_LOINC	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.601	PIM_Vitamin B12 Level_CPT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.604	PIM_Glyburide	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.605	PIM_Pioglitazone	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.606	PIM_Semaglutide	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.607	PIM_Linagliptin	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.609	Macrolide_Azithromycin	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.61	Secondary antihypertensives	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.610	Long Acting Beta Agonists (LABA) Non_Formoterol	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.612	Wolff Parkinson White SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.613	Wolff Parkinson White I10	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.614	Wolff Parkinson White	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.615	medications_Asthma	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.619	ICS_LABA_LAMA	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.620	Low Dose ICS_LABA_Non Formoterol	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.621	Medium ICS_LABA Non Formoterol	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.623	LAMA Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.624	LABA Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.625	BetaBlock NonCS Secondary Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.626	Eplerenone Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.627	Spironolactone Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.628	SGLT2 Inhibitors Allergy SCT	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.629	PIM_Refill_Request_Antilipemics_LFTs	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.630	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.631	Pneumococcal Vaccine Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.632	Meglitinides Allergy SCT	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.633	DPP4i Allergy SCT	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.635	Alpha_glucosidase inhibitors allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.636	Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.637	Insulins Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.638	TZD Allergy SCT	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.639	T2DM_Medications Allergy SCT	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.642	T2DM_Medications Allergy RXNORM	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.643	T2DM_Medications Allergy SNOMED	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.646	T2DM_Medication Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.647	Statins Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.649	ACE Inhibitors Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.650	ARB Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.652	Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.653	Long Acting Beta Agonists (LABA) Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.654	BetaBlocker NonCS Secondary Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.656	MRA Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.657	Eplerenone Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.658	Spironolactone Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.659	SGLT2i Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.660	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.661	Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.665	Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.666	Human Papillomavirus (HPV) vaccine Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.667	Herpes Zoster Vaccine Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.670	Pneumococcal Vaccine Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.671	Inhaled Corticosteroids(ICS) Allergy Intolerance	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.672	LABA(Formoterol only)	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.674	PIM_Tirzepatide	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.675	GLP1RA Allergy Intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.676	PIM_Diabetes_Testing_Supplies	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.677	PIM_H2_Antagonists	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.678	SGLT2i DM CKD	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.679	SGLT2i DM ASCVD	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.683	OIA_Gout_Medications	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.684	GlumetzaSubstitution	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.685	MetforminER500mg	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.686	PIM_Metformin	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.687	PIM_Glipizide	active	2024-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.689	PIM_Glipizide_Glyburide_Glimepiride	active	2024-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.690	PIM_Insulin_Meglitinides	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.691	PIM_Glyxambi	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.692	PIM_Farxiga	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.693	PIM_Invokana	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.694	PIM_Jardiance	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.695	PIM_Invokana_Jardiance	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.696	Reclast	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.697	LAMA_LABA Combination 1 Inhaler	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.698	PIM_Contraceptives	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.699	Selected Oral Antiemetics for Migraine	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.700	PIM_DEXA_Scan	active	2023-12	us	hl7